ReportWire

Tag: emergency room

  • Lots of people are shoveling their way into the hospital, DC-area doctor says – WTOP News

    [ad_1]

    Whether it be the cold, the shoveling or improper use of heaters, lots of people are ending up in the hospital due to the recent blast of winter weather, one D.C.-area doctor told WTOP.

    Whether it be the cold, the shoveling or an improper use of heaters, lots of people are ending up in the hospital due to the recent blast of winter weather.

    Dr. Miriam Fischer, the senior attending physician in the emergency department at MedStar Health, warned that shoveling this heavy, icy snow comes with dangers.

    “We’re seeing a lot of cardiac events. We’re seeing a lot of muscle strains from lifting and shoveling and pushing that snow,” Fischer said.

    Fischer said the risk of exhaustion is compounded by the extreme cold. It can make it harder to feel when you’re overdoing it.

    “Some of us are out of shape and you go out and you’re lifting snow, and your body is just not ready to do it,” she said.

    The bigger danger is the cold itself. Experts advise keeping trips outside brief, layering up and wearing hats and gloves while braving the bitter cold temperatures.

    Many people are ending up in the emergency room with hypothermia and frost bite, Fischer said.

    “Thirteen degrees Fahrenheit, -10 degrees Celsius, frostbite can set in in less than 30 minutes,” she said.

    A lot of us also use space heaters to keep warm, but Fischer said that comes with a risk, too.

    “They can also cause fire and they can produce gas, so don’t leave then unattended. Don’t use them in an enclosed space,” she said.

    She’s also telling people, especially dialysis patients, not to cancel appointments.

    “We are available. We are open. Make sure you can get to dialysis. Make sure you have a plan to get there. Make sure you are taking your meds,” Fischer said.

    Get breaking news and daily headlines delivered to your email inbox by signing up here.

    © 2026 WTOP. All Rights Reserved. This website is not intended for users located within the European Economic Area.

    [ad_2]

    Kyle Cooper

    Source link

  • Fact-checking Florida AG on abortion pill hospitalizations

    [ad_1]

    Florida Attorney General James Uthmeier is suing Planned Parenthood for what he called deceptive marketing practices involving abortion pills.

    In a Nov. 6 video on X, Uthmeier said Planned Parenthood “falsely marketed to women” that abortion pills are safer than over-the-counter medications.

    “Evidence suggests that 1 in 25 women who consume these dangerous pills are hospitalized,” Uthmeier said. “And we’ve seen dozens of reported deaths. This is wrong, and we’re going to hold them accountable.”

    Although Uthmeier used the word “hospitalized” to describe the outcome, text that appeared on screen in the video as he spoke said 1 in 25 women “end up in the ER,” a figure that combines results from two studies Uthmeier cited. Emergency department visits are not the same as hospitalizations, which involve patients being formally admitted. 

    When contacted for evidence, Uthmeier’s spokesperson pointed PolitiFact to a table in the U.S. Food and Drug Administration’s label for mifepristone, the first of two pills taken in early pregnancy for medication abortion. One line in the table said two U.S. studies with 1,043 women found a 2.9% to 4.6% frequency rate for ER visits. The higher end of the range roughly correlates to 1 in 25 women.

    Besides conflating hospitalizations and ER visits, Uthmeier cited studies with small sample sizes; multiple larger studies found lower rates of both ER visits and hospitalizations following medication abortion. Researchers told PolitiFact emergency department visits are not a reliable indicator of drug safety and are not proof that patients experienced serious adverse events or were admitted to the hospital.

    “In large studies of medication abortion, hospitalization is very rare, generally occurring in <0.5% of patients,” Dr. Daniel Grossman, a professor of obstetrics, gynecology and reproductive sciences at the University of California, San Francisco, wrote in an email to PolitiFact. Grossman said ER visits are more common because patients who do not live near their provider might have to go to an emergency department for anything that requires in-person consultation, including to confirm an abortion was successful. 

    The FDA label that Uthmeier cited also showed hospitalization rates of 0.04% to 0.06% among 14,339 women evaluated in three studies, or about 86 women on the higher end of the range.

    The FDA label does not include the research methodology or details about the cases. The FDA didn’t answer our questions about the studies.

    Danco Laboratories, which manufactures and distributes mifepristone under the brand name Mifeprex, provided the studies to PolitiFact. The two reports showed 41 women out of 1,043 visited the ER after taking abortion pills. Eight of the 41 were hospitalized and, of those, three were admitted for unrelated reasons, including pancreatitis and hip pain. That means five out of 1,043 women evaluated were hospitalized for reasons related to abortion pills.

    “The actual percentage of related serious adverse events that required hospital admission in these two studies was 0.5%,” said Ushma Upadhyay, a professor and public health scientist at the University of California, San Francisco.

    What is medication abortion and how safe is it?

    Medication abortion is approved in the U.S. up to the 10th week of pregnancy and involves two medicines — mifepristone and misoprostol — that are typically taken 24 hours apart. Studies have found that around 95% to 98% of patients who take the medicines as prescribed will end their pregnancies without  complication.

    The FDA has repeatedly reaffirmed mifepristone’s safety since the drug was first approved in 2000. (Misoprostol has been on the market longer and has different uses, including preventing stomach ulcers.)

    Medication abortions are common, accounting for 63% of all abortions in the U.S. in 2023, according to the Guttmacher Institute, a research organization that supports reproductive rights. More than 5 million women in the U.S. have used abortion pills to terminate pregnancies.

    Over 100 studies spanning decades have found medication abortion to be safe and effective. 

    “We’ve been using mifepristone in the U.S. for over two decades and we aren’t seeing legitimate studies that are documenting any medical fallout or medical complications from this drug,” said Rachel Jones, Guttmacher Institute principal research scientist.

    Medication abortion and ER visits, hospitalizations

    Research shows abortion pills are not associated with a high percentage of emergency room visits or hospitalizations.

    The studies Uthmeier pointed to did not prove that medication abortion is dangerous, experts said

    One of the studies, published in 2012, acknowledged that major adverse events attributable to medication abortion, such as hospitalizations, emergency department visits and blood transfusions, are “rare.” 

    The vast majority of mifepristone research is in line with this.   

    A 2013 study that examined 233,805 medication abortions by Planned Parenthood in 2009 and 2010 found an emergency department treatment rate of 0.1%, and said significant adverse events requiring hospital admission occurred in 0.16% of cases.

    A 2015 study on emergency room visits and complications after 55,000 abortions — 11,000 of which were medication abortions — found that serious adverse events occurred in 0.3% of all cases.

    Emergency department visits alone are not indicative of adverse events, Upadhyay, the 2015 study’s lead author, told PolitiFact.

    A 2018 study found around 51% of abortion-related ER visits involved observational care only. “This really shows that people go to the emergency department to have their questions answered. They aren’t getting any treatment. They are being observed and released,” Upadhyay said.

    U.S. Health and Human Services Secretary Robert F. Kennedy Jr. and FDA Commissioner Dr. Marty Makary have promised to launch another mifepristone safety review. The top health officials have referenced studies that experts say have several problems.

    For example, one April report by the Ethics and Public Policy Center, a conservative nonprofit that opposes abortion, found a substantially higher rate of serious side effects from the drug compared with other studies.

    The report wasn’t peer-reviewed or published in a medical journal. It didn’t disclose its data source and contained multiple methodological issues, 263 reproductive health researchers wrote in a letter to the FDA. Uthmeier cites the report in Florida’s lawsuit against Planned Parenthood.

    Our ruling

    Uthmeier said, “Evidence suggests that 1 in 25 women who consume (abortion) pills are hospitalized.”

    Uthmeier conflated hospitalizations with emergency department visits. Roughly 1 in 25 women visited the ER in the two studies Uthmeier cited, but only five out of 1,043 — or 1 in 200 — were hospitalized related to the abortion pill.

    ER visits, which can often involve only observational care followed by release, are not a reliable indicator of drug safety, researchers said, and do not mean patients experienced a serious adverse event or were admitted to the hospital.

    Several other studies found lower rates of ER treatment and hospitalizations following medication abortion.

    Uthmeier’s statement contains an element of truth but ignores critical facts that would give a different impression. We rate it Mostly False.  

    PolitiFact Researcher Caryn Baird contributed to this report.

    [ad_2]

    Source link

  • Thousands of children are landing in the ER after ingesting melatonin without supervision

    Thousands of children are landing in the ER after ingesting melatonin without supervision

    [ad_1]

    Melatonin products have become increasingly popular among U.S. adults and a new report from the U.S. Centers for Disease Control and Prevention says about 11,000 children have landed in the emergency room in recent years after ingesting it while unsupervised.File video above: Chronic misuse of melatonin creating health concernsMelatonin is a hormone produced by the brain in response to darkness and regulates the body’s natural sleep-wake cycle, or circadian rhythm. Melatonin supplements, often sold as flavored gummies, can help someone struggling to fall asleep due to jet lag or sleep-wake disorders commonly seen in shift workers.For the new report, researchers from the CDC and U.S. Consumer Product Safety Commission identified cases involving children age 5 and younger who were taken to the emergency department between 2019 and 2022 after ingesting melatonin without supervision.Based on nearly 300 identified cases, the researchers estimated that 10,930 emergency department visits occurred during that time period, accounting for about 7% of all ER visits in the U.S. for unsupervised medication exposures in infants and young children.More than half of accidental ingestions involved children between 3 and 5 years old and the majority of visits did not involve additional medications.While the type of melatonin ingested was not specified during most visits, the report shows that children had almost always swallowed the product. Based on emergency department visits where the dosage form was specified, researchers estimated that melatonin gummies were involved in nearly 5,000 cases.Melatonin is a supplement and is not regulated by the U.S. Food and Drug Administration. A recent study published in the journal JAMA found that 25 products labeled as melatonin gummies contained dangerous levels of the hormone while other contained no melatonin and contained only cannabidiol, or CBD.”These discrepancies in ingredients or strength could pose additional risk” to children, the CDC researchers wrote.Among emergency department visits with documentation of the melatonin container, about three-quarters involved bottles — suggesting that young children were able to open the bottles or that the bottles were not closed properly.The researchers said it is important for adults who take these products and live in homes with young children to consider buying melatonin products with child-resistant packaging.Meanwhile, the surveillance data used in the report comes with limitations, including a lack of “narrative” information recorded during emergency department visits. For example, the intended age of a melatonin product was not specified in nearly half of visits, therefore the involvement of a specific product type might be higher than reported.Analyzing cases of unsupervised melatonin ingestion in young children during emergency department visits also underestimates the frequency of melatonin ingestions by children 5 and under, the researchers said.The use of melatonin by U.S. adults soared since the early 2000s, the CDC noted. The rise coincided with a 420% increase in emergency department visits for unsupervised melatonin ingestion by infants and young children between 2009 and 2020.The new report says that the vast majority of unsupervised melatonin ingestions did not result in hospitalization.However, more research is needed to determine if supervised use of melatonin for children is safe or needed. The use of melatonin appears “to be safe for most children for short-term use,” according to the National Center for Complementary and Integrative Health, a department of the National Institutes of Health, but it points out that it is unclear how much melatonin is suitable for children and whether its benefits outweigh its possible risks.In general, melatonin side effects documented in children include drowsiness, headaches, agitation and increased bed-wetting or urination in the evening, according to the NCCIH. There is also the potential for harmful interactions with drugs sometimes prescribed for children’s allergic reactions.The researchers for the latest study did not specify whether the children included in the surveillance data experienced any side effects.Parents should always consult their pediatrician before giving their children melatonin, according to Dr. Cora Collette Breuner, a professor in the department of pediatrics at Seattle Children’s Hospital at the University of Washington.”I also tell families, this is not something your child should take forever. Nobody knows what the long-term effects of taking this is on your child’s growth and development,” Breuner previously told CNN.”Taking away blue-light-emitting smartphones, tablets, laptops and television at least two hours before bed will keep melatonin production humming along, as will reading or listening to bedtime stories in a softly lit room, taking a warm bath, or doing light stretches.”CNN’s Sandee LaMotte contributed to this report.

    Melatonin products have become increasingly popular among U.S. adults and a new report from the U.S. Centers for Disease Control and Prevention says about 11,000 children have landed in the emergency room in recent years after ingesting it while unsupervised.

    File video above: Chronic misuse of melatonin creating health concerns

    Melatonin is a hormone produced by the brain in response to darkness and regulates the body’s natural sleep-wake cycle, or circadian rhythm. Melatonin supplements, often sold as flavored gummies, can help someone struggling to fall asleep due to jet lag or sleep-wake disorders commonly seen in shift workers.

    For the new report, researchers from the CDC and U.S. Consumer Product Safety Commission identified cases involving children age 5 and younger who were taken to the emergency department between 2019 and 2022 after ingesting melatonin without supervision.

    Based on nearly 300 identified cases, the researchers estimated that 10,930 emergency department visits occurred during that time period, accounting for about 7% of all ER visits in the U.S. for unsupervised medication exposures in infants and young children.

    More than half of accidental ingestions involved children between 3 and 5 years old and the majority of visits did not involve additional medications.

    While the type of melatonin ingested was not specified during most visits, the report shows that children had almost always swallowed the product. Based on emergency department visits where the dosage form was specified, researchers estimated that melatonin gummies were involved in nearly 5,000 cases.

    Melatonin is a supplement and is not regulated by the U.S. Food and Drug Administration. A recent study published in the journal JAMA found that 25 products labeled as melatonin gummies contained dangerous levels of the hormone while other contained no melatonin and contained only cannabidiol, or CBD.

    “These discrepancies in ingredients or strength could pose additional risk” to children, the CDC researchers wrote.

    Among emergency department visits with documentation of the melatonin container, about three-quarters involved bottles — suggesting that young children were able to open the bottles or that the bottles were not closed properly.

    The researchers said it is important for adults who take these products and live in homes with young children to consider buying melatonin products with child-resistant packaging.

    Meanwhile, the surveillance data used in the report comes with limitations, including a lack of “narrative” information recorded during emergency department visits. For example, the intended age of a melatonin product was not specified in nearly half of visits, therefore the involvement of a specific product type might be higher than reported.

    Analyzing cases of unsupervised melatonin ingestion in young children during emergency department visits also underestimates the frequency of melatonin ingestions by children 5 and under, the researchers said.

    The use of melatonin by U.S. adults soared since the early 2000s, the CDC noted. The rise coincided with a 420% increase in emergency department visits for unsupervised melatonin ingestion by infants and young children between 2009 and 2020.

    The new report says that the vast majority of unsupervised melatonin ingestions did not result in hospitalization.

    However, more research is needed to determine if supervised use of melatonin for children is safe or needed. The use of melatonin appears “to be safe for most children for short-term use,” according to the National Center for Complementary and Integrative Health, a department of the National Institutes of Health, but it points out that it is unclear how much melatonin is suitable for children and whether its benefits outweigh its possible risks.

    In general, melatonin side effects documented in children include drowsiness, headaches, agitation and increased bed-wetting or urination in the evening, according to the NCCIH. There is also the potential for harmful interactions with drugs sometimes prescribed for children’s allergic reactions.

    The researchers for the latest study did not specify whether the children included in the surveillance data experienced any side effects.

    Parents should always consult their pediatrician before giving their children melatonin, according to Dr. Cora Collette Breuner, a professor in the department of pediatrics at Seattle Children’s Hospital at the University of Washington.

    “I also tell families, this is not something your child should take forever. Nobody knows what the long-term effects of taking this is on your child’s growth and development,” Breuner previously told CNN.

    “Taking away blue-light-emitting smartphones, tablets, laptops and television at least two hours before bed will keep melatonin production humming along, as will reading or listening to bedtime stories in a softly lit room, taking a warm bath, or doing light stretches.”

    CNN’s Sandee LaMotte contributed to this report.

    [ad_2]

    Source link

  • Even With Insurance, ERs Can Cost a Bundle

    Even With Insurance, ERs Can Cost a Bundle

    [ad_1]

    Jan. 4, 2023 – If you’ve gone to the emergency room recently, you likely know how much such a visit can cost. A new study by researchers at the Kaiser Family Foundation finds that even for people with private insurance who are employed by large companies, the average out-of-pocket cost of an ER visit can exceed their savings.

    In 2019, the study shows, patients enrolled in big companies’ health plans paid an average of $646 in copays and deductibles for each ER visit. A quarter of visits cost more than $907 out of pocket, and another quarter cost under $128.

    About half of households can’t afford to pay the average deductible in an employer-sponsored insurance plan, the report notes. And more than a third of U.S. adults are unable to afford a $400 medical expense without borrowing. 

    While it’s not known how many people don’t go to an emergency room because of the anticipated cost, almost half of U.S. adults report that they’ve delayed care due to costs, according to a recent Kaiser survey.

    One problem that people often face when deciding whether to visit an ER is that they don’t know how serious their condition is and what emergency care will cost, says Hope Schwartz, lead author of the report.

    “When they go to the [ER], they don’t always know what their diagnosis will be and what their treatment costs will be. What we highlighted is that those costs could be very high or very low, and there’s no way to tell beforehand,” she says.

    What Costs So Much?

    Based on the paid claims data used in the study, health plans and patients paid a combined average of $2,453 for an ER visit. A quarter of visits cost $970 or less, and a quarter cost $3,043 or more.

    Emergency room claims include professional fees and facility fees. The facility fees, which cover the cost of a hospital maintaining an ER 24/7, made up 80% of total costs, including a portion of doctors’ claims as well as laboratory and imaging fees. 

    But doctors’ claims for evaluation and management services were the largest part of costs, averaging $1,134 per visit. Procedures and treatments cost over $1,100 per visit, on average, while the average imaging claim cost $483, and the average cost for lab work was $230. 

    Over half of visits generated imaging claims, and about half of visits included lab claims.

    The Kaiser Family Foundation report also looked at the costs of several common ER diagnoses. The most expensive diagnosis was appendicitis, which cost nearly twice as much as heart attacks, partly because it often led to surgery in the emergency room. On average, a visit for appendicitis cost $9,535, of which $1,717 was an out-of-pocket expense.

    In addition, the researchers examined lower-cost diagnoses that generally do not require imaging or extensive treatment in the ER. These included upper respiratory tract infections ($1,535 total, $523 out of pocket), skin and soft tissue infections ($2,005 total, $572 out of pocket), and urinary tract infections ($2,726 total, $683 out of pocket). 

    While these diagnoses can sometimes require admission to the hospital, in otherwise healthy adults they are typically evaluated with basic lab tests, and patients are discharged with prescriptions, according to the report.

    Complexities of Billing

    ER visits are given codes to help show how complex the task or service was during the billing process. These codes have five levels. 

    Less complex visits require straightforward medical decision-making, such as rashes or medication refills. Patients with level 5 codes require highly complex decision-making and include life- or limb-threatening conditions, such as severe infections or heart attacks.

    The less complex visits cost $592, on average, with patients responsible for $205 of that. For the most complex visits, the health plan covered $3,015, on average, or eight times the cost of the lowest-coded visits. 

    On average, patients paid $840 out of pocket for the most complex visits — four times the average costs for the less complex visits.

    One reason for the rise in spending for ER visits is a national shift to higher-level ER billing codes, says Schwartz, who is a Kaiser Family Foundation health policy fellow and a medical student, “There has been good work done showing that [ER] visits are increasingly being billed as a level 4 or 5, whereas in previous years, they might have been billed as a level 3.

    “Whether a hospital bills a level 4 or a level 5 code for your visit can make a really big difference in how much you pay. And if you come in not knowing what services you’re going to get, you don’t know if you’re going to get a level 3, 4, or 5 code, and the costs increase pretty quickly,” she says. 

    Costs Vary by Region

    The report includes an analysis of emergency room costs in the 20 largest metropolitan areas in the U.S. Overall, the researchers found, San Diego had the most expensive ER visits. Emergency rooms in San Diego charged about twice as much per visit, on average, as those in Baltimore.

    While there were expensive areas all across the country, many of the costliest places were in Texas, Florida, California, Colorado, and New York. The report noted that the most expensive regions for ER care did not align with the regions that had the most expensive health care overall. 

    “These comparisons suggest that our findings are not solely related to overall high health care prices in these areas and may reflect other factors, including the age and medical complexity of the population or differences in local norms and practice patterns,” the report says.

    Healthier People

    In addition to these geographical differences, the incidence of emergency room visits by those with employers’ insurance differed from that of the general population.

    During the study year, the report found, 12% of the insured had at least one ER visit — a percentage that didn’t vary for any age group under 65, including children. (No patients 65 or older were included in the study.) 

    By comparison, a government survey shows that in 2019, 21% of all U.S. adults 18 to 44 had one or more emergency room visits. Among those 45 to 64, 20% made at least one ER visit.

    [ad_2]

    Source link

  • Computers May Have Cracked the Code to Diagnosing Sepsis

    Computers May Have Cracked the Code to Diagnosing Sepsis

    [ad_1]

    This article was originally published in Undark Magazine.

    Ten years ago, 12-year-old Rory Staunton dove for a ball in gym class and scraped his arm. He woke up the next day with a 104-degree Fahrenheit fever, so his parents took him to the pediatrician and eventually the emergency room. It was just the stomach flu, they were told. Three days later, Rory died of sepsis after bacteria from the scrape infiltrated his blood and triggered organ failure.

    “How does that happen in a modern society?” his father, Ciaran Staunton, asked me.

    Each year in the United States, sepsis kills more than a quarter million people—more than stroke, diabetes, or lung cancer. One reason for all this carnage is that if sepsis is not detected in time, it’s essentially a death sentence. Consequently, much research has focused on catching sepsis early, but the condition’s complexity has plagued existing clinical support systems—electronic tools that use pop-up alerts to improve patient care—with low accuracy and high rates of false alarm.

    That may soon change. Back in July, Johns Hopkins researchers published a trio of studies in Nature Medicine and npj Digital Medicine showcasing an early-warning system that uses artificial intelligence. The system caught 82 percent of sepsis cases and significantly reduced mortality. While AI—in this case, machine learning—has long promised to improve health care, most studies demonstrating its benefits have been conducted using historical data sets. Sources told me that, to the best of their knowledge, when used on patients in real time, no AI algorithm has shown success at scale. Suchi Saria, the director of the Machine Learning and Healthcare Lab at Johns Hopkins University and the senior author of the studies, said in an interview that the novelty of this research is how “AI is implemented at the bedside, used by thousands of providers, and where we’re seeing lives saved.”

    The Targeted Real-Time Early Warning System scans through hospitals’ electronic health records—digital versions of patients’ medical histories—to identify clinical signs that predict sepsis, alert providers about at-risk patients, and facilitate early treatment. Leveraging vast amounts of data, TREWS provides real-time patient insights and a unique level of transparency in its reasoning, according to the Johns Hopkins internal-medicine physician Albert Wu, a co-author of the study.

    Wu says that this system also offers a glimpse into a new age of medical electronization. Since their introduction in the 1960s, electronic health records have reshaped how physicians document clinical information; nowadays, however, these systems primarily serve as “an electronic notepad,” he added. With a series of machine-learning projects on the horizon, both from Johns Hopkins and other groups, Saria says that using electronic records in new ways could transform health-care delivery, providing physicians with an extra set of eyes and ears—and helping them make better decisions.

    It’s an enticing vision, but one in which Saria, the CEO of the company developing TREWS, has a financial stake. This vision also discounts the difficulties of implementing any new medical technology: Providers might be reluctant to trust machine-learning tools, and these systems might not work as well outside controlled research settings. Electronic health records also come with many existing problems, from burying providers under administrative work to risking patient safety because of software glitches.

    Saria is nevertheless optimistic. “The technology exists; the data is there,” she says. “We really need high-quality care-augmentation tools that will allow providers to do more with less.”


    Currently, there’s no single test for sepsis, so health-care providers have to piece together their diagnoses by reviewing a patient’s medical history, conducting a physical exam, running tests, and relying on their own clinical impressions. Given such complexity, over the past decade, doctors have increasingly leaned on electronic health records to help diagnose sepsis, mostly by employing a rules-based criteria—if this, then that.

    One such example, known as the SIRS criteria, says a patient is at risk of sepsis if two of four clinical signs—body temperature, heart rate, breathing rate, white-blood-cell count—are abnormal. This broadness, although helpful for catching the various ways sepsis might present itself, triggers countless false positives. Take a patient with a broken arm: “A computerized system might say, ‘Hey, look, fast heart rate, breathing fast.’ It might throw an alert,” says Cyrus Shariat, an ICU physician at Washington Hospital in California. The patient almost certainly doesn’t have sepsis but would nonetheless trip the alarm.

    These alerts also appear on providers’ computer screens as a pop-up, which forces them to stop whatever they’re doing to respond. So, despite these rules-based systems occasionally reducing mortality, there’s a risk of alert fatigue, where health-care workers start ignoring the flood of irritating reminders. According to M. Michael Shabot, a surgeon and the former chief clinical officer of Memorial Hermann Health System, “It’s like a fire alarm going off all the time. You tend to be desensitized. You don’t pay attention to it.”

    Already, electronic records aren’t particularly popular among doctors. In a 2018 survey, 71 percent of physicians said that the records greatly contribute to burnout, and 69 percent said that they take valuable time away from patients. Another 2016 study found that, for every hour spent on patient care, physicians have to devote two extra hours to electronic health records and desk work. James Adams, the chair of the Department of Emergency Medicine at Northwestern University, calls electronic health records a “congested morass of information.”

    But Adams also says that the health-care industry is at an inflection point to transform the files. An electronic record doesn’t have to simply involve a doctor or nurse putting data in, he says; instead, it “needs to transform to be a clinical-care-delivery tool.” With their universal deployment and real-time patient data, electronic records could warn providers about sepsis and various other conditions—but that will require more than a rules-based approach.

    What doctors need, according to Shabot, is an algorithm that can integrate various streams of clinical information to offer a clearer, more accurate picture when something’s wrong.


    Machine-learning algorithms work by looking for patterns in data to predict a particular outcome, like a patient’s risk of sepsis. Researchers train the algorithms on existing data sets, which helps the algorithms create a model for how that world works and then make predictions on new data sets. The algorithms can also actively adapt and improve over time, without the interference of humans.

    TREWS follows this general mold. The researchers first trained the algorithm on historical electronic-records data so that it could recognize early signs of sepsis. After this testing showed that TREWS could have identified patients with sepsis hours before they actually got treatment, the algorithm was deployed inside hospitals to influence patient care in real time.

    Saria and Wu published three studies on TREWS. The first tried to determine how accurate the system was, whether providers would actually use it, and if use led to earlier sepsis treatment. The second went a step further to see if using TREWS actually reduced patient mortality. And the third interviewed 20 providers who tested the tool on what they thought about machine learning, including what factors facilitate versus hinder trust.

    In these studies, TREWS monitored patients in the emergency department and inpatient wards, scanning through their data—vital signs, lab results, medications, clinical histories, and provider notes—for early signals of sepsis. (Providers could do this themselves, Saria says, but it might take them about 20 to 40 minutes.) If the system suspected organ dysfunction based on its analysis of millions of other data points, it flagged the patient and prompted providers to confirm sepsis, dismiss the alert, or temporarily pause the alert.

    “This is a colleague telling you, based upon data and having reviewed all this person’s chart, why they believe there’s reason for concern,” Saria says. “We very much want our frontline providers to disagree, because they have ultimately their eyes on the patient.” And TREWS continuously learns from these providers’ feedback. Such real-time improvements, as well as the diversity of data TREWS considers, are what distinguish it from other electronic-records tools for sepsis.

    In addition to these functional differences, TREWS doesn’t alert providers with incessant pop-up boxes. Instead, the system uses a more passive approach, with alerts arriving as icons on the patient list that providers can click on later. Initially, Saria was worried this might be too passive: “Providers aren’t going to listen. They’re not going to agree. You’re mostly going to get ignored.” However, clinicians responded to 89 percent of the system’s alerts. One physician interviewed for the third study described TREWS as less “irritating” than the previous rules-based system.

    Saria says that TREWS’s high adoption rate shows that providers will trust AI tools. But Fei Wang, an associate professor of health informatics at Weill Cornell Medicine, is more skeptical about how these findings will hold up if TREWS is deployed more broadly. Although he calls these studies first-of-a-kind and thinks their results are encouraging, he notes that providers can be conservative and resistant to change: “It’s just not easy to convince physicians to use another tool they are not familiar with,” Wang says. Any new system is a burden until proven otherwise. Trust takes time.

    TREWS is further limited because it only knows what’s been inputted into the electronic health record—the system is not actually at the patient’s bedside. As one emergency-department physician put it, in an interview for the third study, the system “can’t help you with what it can’t see.” And even what it can see is filled with missing, faulty, and out-of-date data, according to Wang.

    But Saria says that TREWS’s strengths and limitations complement those of health-care providers. Although the algorithm can analyze massive amounts of clinical data in real time, it will always be limited by the quality and comprehensiveness of the electronic health record. The goal, Saria adds, is not to replace physicians, but to partner with them and augment their capabilities.


    The most impressive aspect of TREWS, according to Zachary Lipton, an assistant professor of machine learning and operations research at Carnegie Mellon University, is not the model’s novelty, but the effort it must have taken to deploy it on 590,736 patients across five hospitals over the course of the study. “In this area, there is a tremendous amount of offline research,” Lipton says, but relatively few studies “actually make it to the level of being deployed widely in a major health system.” It’s so difficult to perform research like this “in the wild,” he adds, because it requires collaborations across various disciplines, from product designers to systems engineers to administrators.

    As such, by demonstrating how well the algorithm worked in a large clinical study, TREWS has joined an exclusive club. But this uniqueness may be fleeting. Duke University’s Sepsis Watch algorithm, for one, is currently being tested across three hospitals following a successful pilot phase, with more data forthcoming. In contrast with TREWS, Sepsis Watch uses a type of machine learning called deep learning. Although this can provide more powerful insights, how the deep-learning algorithm comes to its conclusions is unexplainable—a situation that computer scientists call the black-box problem. The inputs and outputs are visible, but the process in between is impenetrable.

    On the one hand, there’s the question of whether this is really a problem: Doctors don’t always know how drugs work, Adams says, “but at some point, we have to trust what the medicine is doing.” Lithium, for example, is a widely used, effective treatment for bipolar disorder, but nobody really understands exactly how it works. If an AI system is similarly useful, maybe interpretability doesn’t matter.

    Wang suggests that that’s a dangerous conclusion. “How can you confidently say your algorithm is accurate?” he asks. After all, it’s difficult to know anything for sure when a model’s mechanics are a black box. That’s why TREWS, a simpler algorithm that can explain itself, might be a more promising approach. “If you have this set of rules,” Wang says, “people can easily validate that everywhere.”

    Indeed, providers trusted TREWS largely because they could see descriptions of the system’s process. Of the clinicians interviewed, none fully understood machine learning, but that level of comprehension wasn’t necessary.


    In machine learning, although the specific algorithmic design is important, the results have to speak for themselves. By catching 82 percent of sepsis cases and reducing time to antibiotics by 1.85 hours, TREWS ultimately reduced patient deaths. “This tool is, No. 1, very good; No. 2, received well by clinicians; and No. 3, impacts mortality,” Adams says. “That combination makes it very special.”

    However, Shariat, the ICU physician at Washington Hospital in California, was more cautious about these findings. For one, these studies only compared patients with sepsis who had the TREWS alert confirmed within three hours to those who didn’t. “They’re just telling us that this alert system that we’re studying is more effective if someone responds to it,” Shariat says. A more robust approach would have been to conduct a randomized controlled trial—the gold standard of medical research—where half of patients got TREWS in their electronic record while the other half didn’t. Saria says that randomization would have been difficult to do given patient-safety concerns, and Shariat agrees. Even so, he says that the absence “makes the data less rigorous.”

    Shariat also worries that the sheer volume of alerts, with about two out of three being false positives, might contribute to alert fatigue—and potentially overtreatment with fluids and antibiotics, which can lead to serious medical complications such as pulmonary edema and antibiotic resistance. Saria acknowledges that TREWS’s false-positive rate, although lower than that of existing electronic-health-record systems, could certainly improve, but says it will always be crucial for clinicians to continue to use their own judgment.

    The studies also have a conflict of interest: Saria is entitled to revenue distribution from TREWS, as is Johns Hopkins. “If this goes prime time, and they sell it to every hospital, there’s so much money,” Shariat says. “It’s billions and billions of dollars.”

    Saria maintains that these studies went through rigorous internal and external review processes to manage conflicts of interest, and that the vast majority of study authors don’t have a financial stake in this research. Regardless, Shariat says it will be crucial to have independent validation to confirm these findings and ensure the system is truly generalizable.

    The Epic Sepsis Model, a widely used algorithm that scans through electronic records but doesn’t use machine learning, is a cautionary example here, according to David Bates, the chief of general internal medicine at Brigham and Women’s Hospital. He explains that the model was developed at a few health systems with promising results before being deployed at hundreds of others. The model then deteriorated, missing two-thirds of patients with sepsis and having a concerningly high false-positive rate. “You can’t really predict how much the performance is going to degrade,” Bates says, “without actually going and looking.”

    Despite the potential drawbacks, Orlaith Staunton, Rory’s mother, told me that TREWS could have saved her son’s life. “There was complete breakdown in my son’s situation,” she said; none of his clinicians considered sepsis until it was too late. An early-warning system that alerted them about the condition, she added, “would make the world of difference.”

    After Rory’s death, the Stauntons started the organization End Sepsis to ensure that no other family would have to go through their pain. In part because of their efforts, New York State mandated that hospitals develop sepsis protocols, and the CDC launched a sepsis-education campaign. But none of this will ever bring back Rory, Ciaran Staunton said: “We will never be happy again.”

    This research is personal for Saria as well. Almost a decade ago, her nephew died of sepsis. By the time it was discovered, there was nothing his doctors could do. “It all happened too quickly, and we lost him,” she says. That’s precisely why early detection is so important—life and death can be mere minutes away. “Last year, we flew helicopters on Mars,” Saria says, “but we’re still freaking killing patients every day.”

    [ad_2]

    Simar Bajaj

    Source link